Cefoxitin sodium crystalline compound

A technology for cefoxitin sodium and a compound, applied in the field of medicine, can solve the problems of not meeting the requirements of cefoxitin sodium for normal temperature preservation, not giving inspection data and the like

Inactive Publication Date: 2018-06-29
BEIJING RED SUN PHARMA +1
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But above-mentioned crystal form all can not satisfy the requirement that cefoxitin sodium is stored at room temperature in the whole shelf life (24 months).
The master's thesis of Hebei University of Science and Technology "Synthesis and Stability of Cefoxitin S

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefoxitin sodium crystalline compound
  • Cefoxitin sodium crystalline compound
  • Cefoxitin sodium crystalline compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1: Cefoxitin sodium crystal form compound

[0031] Take 50 g of crude cefoxitin sodium and add it to 100 mL of water, heat and stir until it is completely dissolved to obtain an aqueous solution of cefoxitin sodium, then add 5 g of activated carbon, stir for 30 minutes, filter while it is hot, control the filtrate at 85 ° C, and slowly Add dropwise a mixed solution of absolute ethanol and methanol, the volume ratio of the mixed solution absolute ethanol to methanol is 12:1, until the solution appears turbid, stir to room temperature, continue to stir for 30 minutes, stand overnight, filter, and dry Obtained as white powdery crystals. The purity was 99.4% by HPLC.

[0032] The X-ray powder diffraction pattern obtained by measuring the cefoxitin sodium crystal form compound obtained using Cu-Kα rays is as follows: figure 1 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine and particularly relates to a cefoxitin sodium crystalline compound shown as formula (I) in the description. An X-ray powder diffraction pattern of the compound under measurement with Cu-Kalpha rays is shown as figure 1. The cefoxitin sodium crystalline compound has better stability and can be stored at room temperature, and storage cost andtransport cost of the drug are reduced effectively.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a crystal form compound of cefoxitin sodium and a preparation method thereof. Background technique [0002] The chemical name of Cefoxitin Sodium is: (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[2(2-thienyl) Acetylamino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt. Its chemical structural formula is: [0003] [0004] Cefoxitin Sodium is a brand-new cephalosporin antibiotic drug developed by Merck & Co. of the United States, which was introduced into the Chinese market in 1992. The product has a broad antibacterial spectrum, strong activity against Gram-positive bacteria, negative bacteria, anaerobic bacteria or aerobic bacteria, highly stable to β-lactamase, wide distribution in the body, and drug in the exudate of infection It has the characteristics of high concentration, and because it is mainly excreted by the kidneys, it has sma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D501/57C07D501/12A61K31/546A61P31/04
CPCC07B2200/13C07D501/12C07D501/57
Inventor 林德良
Owner BEIJING RED SUN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products